Acadia Pharmaceuticals reported $-85899000 in EBIT for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Alexion Pharmaceuticals ALXN:US $ 630.8M 116.6M
ALKERMES ALKS:US -30729000 20.06M
Aptinyx Inc APTX:US $ -11423000 10.16M
Biogen BIIB:US $ -166.3M 1345M
Biomarin Pharmaceutical BMRN:US $ -58178000 14.92M
Bristol Myers Squibb BMY:US $ 1150M 809M
Cara Therapeutics CARA:US $ -17020000 14.43M
Cytokinetics CYTK:US $ 5.18M 37.54M
Eisai 4523:JP 23.61B 21.65B
Eli Lilly And LLY:US $ 2358.4M 978.7M
Gw Pharmaceuticals GWPH:US -12721000 11.82M
Intercept Pharmaceuticals ICPT:US $ -43190000 37.99M
Intra Cellular Therapies ITCI:US $ -55936460 49.45M
Johnson & Johnson JNJ:US $ 4819M 1382M
Marinus Pharmaceuticals MRNS:US -15699000 14.11M
Moderna Inc MRNA:US -235117000 112.99M
Neurocrine Biosciences NBIX:US $ 71.8M 2.4M
Pfizer PFE:US $ 2010M 1388M
Ptc Therapeutics PTCT:US $ -55131000 37.46M
Sarepta Therapeutics SRPT:US $ -137068000 123.23M
Seattle Genetics SGEN:US $ 164.99M 473.2M
Vanda Pharmaceuticals VNDA:US $ 12.15M 3.41M
Vertex Pharmaceuticals VRTX:US $ 746.29M 72.25M
YTE INCY:US $ 180.25M 152.83M
Zogenix ZGNX:US $ -60059000 53.06M